Stay updated with breaking news from Clinical Research Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Get latest articles and stories on Health at LatestLY. A new mechanism has been discovered to explain why some prostate tumours move from a common, treatable form to a more rare and severe form of prostate cancer, according to a study from the University of Michigan Rogel Cancer Centre. Health News | Research Shows New Approach to Target Deadly Form of Prostate Cancer.
CORAL GABLES, Fla., Aug. 8, 2023 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today provided a corporate update
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
The addition of the molecular imaging test provides a better risk assessment for cancer recurrence compared to the current standard of care test